Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.
The current price of 9TD.STU is €0.24 EUR — it has increased by +0% in the past 24 hours. Watch Arctic Bioscience AS stock price performance more closely on the chart.
What is Arctic Bioscience AS stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Arctic Bioscience AS stocks are traded under the ticker 9TD.STU.
Is Arctic Bioscience AS stock price growing?▼
9TD.STU stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Arctic Bioscience AS has showed a -32.39% decrease.
When is the next Arctic Bioscience AS earnings date?▼
Arctic Bioscience AS is going to release the next earnings report on April 30, 2026.
How many employees does Arctic Bioscience AS have?▼
As of April 15, 2026, the company has 22 employees.
In which sector is Arctic Bioscience AS located?▼
Arctic Bioscience AS operates in the Health & Wellness sector.
When did Arctic Bioscience AS complete a stock split?▼
Arctic Bioscience AS has not had any recent stock splits.
Where is Arctic Bioscience AS headquartered?▼
Arctic Bioscience AS is headquartered in Ørsta, Other.